United States
Germany
Japan
United Kingdom
China
HES1 mouse monoclonal antibody, clone OTI2D2 (formerly 2D2)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
Antibodies
GLI1 mouse monoclonal antibody, clone OTI4E2 (formerly 4E2)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
Anti-HES1 mouse monoclonal antibody, clone OTI4H1 (formerly 4H1)
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
GLI2 mouse monoclonal antibody, clone OTI1F9 (formerly 1F9)
| Applications | WB |
| Reactivities | Human, Mouse |
OCT4 mouse monoclonal antibody, clone OTI9B7 (formerly 9B7)
| Applications | IF, IHC, WB |
| Reactivities | Human |
CD44 mouse monoclonal antibody, clone OTI1D8 (formerly 1D8)
| Applications | IHC, WB |
| Reactivities | Human |
CD44 mouse monoclonal antibody, clone OTI1E3 (formerly 1E3)
| Applications | FC, IHC, WB |
| Reactivities | Human |
CD44 mouse monoclonal antibody, clone OTI1C8 (formerly 1C8)
| Applications | FC, IHC, WB |
| Reactivities | Human |
CD38 mouse monoclonal antibody,clone OTI1C9
| Applications | IHC, WB |
| Reactivities | Human |
活动过滤器
优化搜索结果
Category
Target Symbol
Reactivities
Antibody Hosts
Knockout (KO) Validation
Conjugates
Clonalities
Pathways
- Pathways in cancer (219)
- Hedgehog signaling pathway (159)
- Basal cell carcinoma (139)
- Calcium signaling pathway (100)
- Dorso-ventral axis formation (85)
- Adherens junction (80)
- Bladder cancer (80)
- Colorectal cancer (80)
- Cytokine-cytokine receptor interaction (80)
- Endocytosis (80)
- Endometrial cancer (80)
- Epithelial cell signaling in Helicobacter pylori infection (80)
- ErbB signaling pathway (80)
- Focal adhesion (80)
- Gap junction (80)
- Glioma (80)
- GnRH signaling pathway (80)
- MAPK signaling pathway (80)
- Melanoma (80)
- Non-small cell lung cancer (80)
- Pancreatic cancer (80)
- Prostate cancer (80)
- Regulation of actin cytoskeleton (80)
- Hematopoietic cell lineage (65)
- TGF-beta signaling pathway (50)
- Notch signaling pathway (41)
- Maturity onset diabetes of the young (36)
- ECM-receptor interaction (35)
- Metabolic pathways (20)
- Nicotinate and nicotinamide metabolism (20)
- Cell adhesion molecules (CAMs) (10)
- Prion diseases (5)
